\u03b1-\u7a81\u89f8\u6838\u86cb\u767d\u5806\u7a4d\uff1a<\/strong> \u9019\u662f\u5df4\u91d1\u68ee\u6c0f\u75c7\u7684\u6a19\u8a8c\u6027\u75c5\u7406\u7279\u5fb5\u3002\u80f0\u5cf6\u7d20\u8a0a\u865f\u7570\u5e38\u6703\u6291\u5236\u7d30\u80de\u6e05\u9664\u5ee2\u7269\u7684\u80fd\u529b\uff08\u81ea\u566c\u4f5c\u7528\uff09\uff0c\u5c0e\u81f4\u9019\u7a2e\u6bd2\u6027\u86cb\u767d\u5728\u5927\u8166\u4e2d\u5927\u91cf\u5806\u7a4d\u3002<\/li>\n<\/ul>\n\n\n\n3. \u81e8\u5e8a\u4e0a\u7684\u8b49\u64da<\/h2>\n\n\n\n
\u7814\u7a76\u6578\u64da\u986f\u793a\uff0c\u9019\u5169\u8005\u4e4b\u9593\u5b58\u5728\u9ad8\u5ea6\u7684\u6b63\u76f8\u95dc\uff1a<\/p>\n\n\n\n
| \u95dc\u806f\u7dad\u5ea6 | \u7814\u7a76\u767c\u73fe |<\/p>\n\n\n\n
| :— | :— |<\/p>\n\n\n\n
| \u60a3\u75c5\u98a8\u96aa<\/strong> | \u7b2c\u4e8c\u578b\u7cd6\u5c3f\u75c5\u60a3\u8005\u7f79\u60a3\u5df4\u91d1\u68ee\u6c0f\u75c7\u7684\u98a8\u96aa\u6bd4\u4e00\u822c\u4eba\u9ad8\u51fa\u7d04 40% – 100%<\/strong>\u3002 |<\/p>\n\n\n\n| \u75c5\u7a0b\u9032\u5c55<\/strong> | \u4f34\u6709\u80f0\u5cf6\u7d20\u963b\u6297\u7684\u5df4\u91d1\u68ee\u60a3\u8005\uff0c\u5176\u904b\u52d5\u969c\u7919\u8207\u8a8d\u77e5\u9000\u5316\u7684\u901f\u5ea6\u901a\u5e38\u8f03\u5feb\u3002 |<\/p>\n\n\n\n| \u85e5\u7269\u555f\u793a<\/strong> | \u4e00\u4e9b\u7528\u65bc\u6cbb\u7642\u7cd6\u5c3f\u75c5\u7684\u85e5\u7269\uff08\u5982 GLP-1 \u53d7\u9ad4\u4fc3\u6548\u5291\uff09\u5728\u81e8\u5e8a\u8a66\u9a57\u4e2d\u986f\u793a\u51fa\u4fdd\u8b77\u795e\u7d93\u3001\u6e1b\u7de9\u5df4\u91d1\u68ee\u75c5\u7a0b\u7684\u6f5b\u529b\u3002 |<\/p>\n\n\n\n
\n\n\n\n\n\u95dc\u9375\u7e3d\u7d50\uff1a<\/strong><\/p>\n\n\n\n\u80f0\u5cf6\u7d20\u963b\u6297\u4e0d\u50c5\u50c5\u662f\u4ee3\u8b1d\u554f\u984c\uff0c\u5b83\u6703\u5275\u9020\u4e00\u500b\u300c\u4ee3\u8b1d\u4e0d\u826f\u300d\u7684\u5927\u8166\u74b0\u5883\uff0c\u8b93\u795e\u7d93\u7d30\u80de\u8b8a\u5f97\u8106\u5f31\uff0c\u9032\u800c\u8a98\u767c\u6216\u52a0\u5287\u5df4\u91d1\u68ee\u6c0f\u75c7\u3002<\/p>\n<\/blockquote>\n\n\n\n
\u9019\u4e5f\u610f\u5473\u8457\uff0c\u900f\u904e\u98f2\u98df\u63a7\u5236\uff08\u5982\u4f4e\u5347\u7cd6\u98f2\u98df\uff09<\/strong>\u3001\u898f\u5f8b\u904b\u52d5<\/strong>\u4ee5\u53ca\u6539\u5584\u4ee3\u8b1d\u5065\u5eb7<\/strong>\uff0c\u53ef\u80fd\u5c0d\u9810\u9632\u6216\u5ef6\u7de9\u5df4\u91d1\u68ee\u6c0f\u75c7\u6709\u7a4d\u6975\u4f5c\u7528\u3002<\/p>\n\n\n\n\u60a8\u662f\u60f3\u4e86\u89e3\u5982\u4f55\u900f\u904e\u98f2\u98df\u4f86\u9810\u9632\u80f0\u5cf6\u7d20\u963b\u6297\uff0c\u9084\u662f\u60f3\u91dd\u5c0d\u7279\u5b9a\u7684\u6cbb\u7642\u85e5\u7269\u7814\u7a76\u505a\u9032\u4e00\u6b65\u63a2\u8a0e\uff1f<\/strong><\/p>\n<\/div>\n\n\n\n\n
This is a very cutting-edge and exciting field of medical research. A growing number of scientists refer to Parkinson’s Disease (PD) as a variant of type 3 diabetes (although the term is most commonly used for Alzheimer’s disease) because research has found a close link between abnormal insulin signaling in the brain and neurodegeneration.<\/p>\n\n\n\n
Here’s a summary of the key connections between the two:<\/p>\n\n\n\n
\n\n\n\n
1. Insulin in the Brain: More Than Just Regulating Blood Sugar<\/h2>\n\n\n\n
In traditional understanding, insulin is responsible for processing blood sugar; however, in the brain, insulin plays the role of a “neuroprotector.” It is responsible for:<\/p>\n\n\n\n
\n- Neuron survival:<\/strong> Helping nerve cells repair and regenerate.<\/li>\n\n\n\n
- Synaptic plasticity:<\/strong> Related to memory and learning functions.<\/li>\n\n\n\n
- Dopamine regulation:<\/strong> Insulin affects the release and reuptake of dopamine in the substantia nigra.<\/li>\n<\/ul>\n\n\n\n
2. How Does Insulin Resistance Cause Parkinson’s Disease?<\/h2>\n\n\n\n
When the brain develops insulin resistance, nerve cells cannot effectively utilize insulin, triggering a chain reaction:<\/p>\n\n\n\n
\n- Mitochondrial Dysfunction:<\/strong> Interrupted insulin signaling causes the cell’s “power plant” (mitochondria) to malfunction, producing excessive free radicals that attack dopamine-secreting neurons.<\/li>\n\n\n\n
- Neuritis:<\/strong> Insulin resistance activates immune cells (microglia) in the brain, leading to chronic inflammation and accelerating nerve death.<\/li>\n\n\n\n
- \u03b1-Synuclein Accumulation:<\/strong> This is a hallmark pathological feature of Parkinson’s disease. Abnormal insulin signaling inhibits the cell’s ability to clear waste (autophagy), causing this toxic protein to accumulate in large quantities in the brain.<\/li>\n<\/ul>\n\n\n\n
3. Clinical Evidence<\/h2>\n\n\n\n
Research data shows a strong positive correlation between these two factors:<\/p>\n\n\n\n
| Correlation Dimension | Research Findings |<\/p>\n\n\n\n
| :— | :— |<\/p>\n\n\n\n
| Risk of Disease<\/strong> | Individuals with type 2 diabetes have approximately 40% – 100%<\/strong> higher risk of developing Parkinson’s disease than the general population. | | Disease Progression<\/strong> | Parkinson’s patients with insulin resistance typically experience faster motor and cognitive decline. | \u200b\u200b| Drug Implications<\/strong> | Some drugs used to treat diabetes (such as GLP-1 receptor agonists) have shown potential in clinical trials to protect nerves and slow the progression of Parkinson’s disease. |<\/p>\n\n\n\n
\n\n\n\n\nKey Summary:<\/strong><\/p>\n<\/blockquote>\n\n\n\nInsulin resistance is not just a metabolic problem; it creates a “metabolic” brain environment that weakens nerve cells, potentially triggering or worsening Parkinson’s disease.<\/p>\n\n\n\n
This also means that dietary control (such as a low-glycemic diet),<\/strong> regular exercise<\/strong>, and improving metabolic health<\/strong> may have a positive effect on preventing or delaying Parkinson’s disease.<\/p>\n\n\n\nAre you interested in learning how to prevent insulin resistance through diet, or would you like to explore specific treatment drug research further?<\/strong><\/p>\n<\/div>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"The relationship between Parkinson’s disease and […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-91","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false},"uagb_author_info":{"display_name":"admin","author_link":"https:\/\/lovejade.org\/?author=1"},"uagb_comment_info":0,"uagb_excerpt":"The relationship between Parkinson’s disease and ...","_links":{"self":[{"href":"https:\/\/lovejade.org\/index.php?rest_route=\/wp\/v2\/posts\/91","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lovejade.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lovejade.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lovejade.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lovejade.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=91"}],"version-history":[{"count":1,"href":"https:\/\/lovejade.org\/index.php?rest_route=\/wp\/v2\/posts\/91\/revisions"}],"predecessor-version":[{"id":92,"href":"https:\/\/lovejade.org\/index.php?rest_route=\/wp\/v2\/posts\/91\/revisions\/92"}],"wp:attachment":[{"href":"https:\/\/lovejade.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=91"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lovejade.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=91"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lovejade.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=91"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}